Low-dose oral use of human interferon-α in cancer patients

Journal of Interferon and Cytokine Research

Volumn 19, Issue 8, 1999, Pages 937-941

  Cummins, Martin J ^a   Pruitt, Brian ^b  

^a Amarillo Biosciences Inc   (United States)

^b Don/Sybil Hamington Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PLACEBO; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANOREXIA; ANTINEOPLASTIC AGENTS; APPETITE STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE I, RECOMBINANT; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 0032840536     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313488     Document Type: Article

References (30)

1. QUESADA, J.R., REUBEN, J., MANNING, J.T., HERSH, E.M., and GUTTERMAN, J.U. (1984). Alpha interferon for induction of remission in hairy-cell leukemia. N. Engl. J. Med. 310, 15-18.
2. LAURIA, F., ZINZANI, P.L., RASPADORI, D., FOA, R., BUZZI, M., GUGLIOTTA, L., BOCCHIA, M., BENFENATI, D., and TURA, S. (1990). Relationship between immunological phenotype and hematological response to α-IFN treatment in 35 patients with hairy cell leukemia. Eur. J. Haematol. 45, 3-6.
3. VEGNA, M.L., PAPA, G., DEFAZIO, D., PISANI, F., COPPOLA, G., DE PITA, O., PUDDU, P., FERRANTI, G., SIMONI, R., and MANDELLI, F. (1990). Interferon alpha-2a in cutaneous T-cell lymphoma. Eur. J. Haematol. 45, 32-35.
4. TALPAZ, M., KANTARJIAN, H.M., MCCREDIE, K., TRULILLO, J.M., KEATING, M.J., and GUTTERMAN, J.U. (1986). Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl. J. Med. 314, 1065-1069.
5. KROWN, S.E. (1991). Interferon and other biologic agents for the treatment of Kaposi's Sarcoma. Hemato. Oncol. Clin. N. Am. 5, 311-322.
6. KRUSIC, J., KIRHMAJER, V., KNEZEVIC, M., IKIC, D., MARICIC, Z., RODE, B., JUSIC, D., and SOOS, E. (1981). Influence of human leukocyte interferon on squamous cell carcinoma of uterine cervix, clinical, histological, and histochemical observations. J. Cancer Res. Clin. Oncol. 101, 309-315.
7. KIRKWOOD, J.M., HARRIS, J.E., VERA, R., SANDLER, S., FISHER, D.S., KHANDEKAR, J., ERNSTOFF, M.S., GORDON, L., LUTES, R., and BONOMI, P. (1985). A randomized study of low and high doses of leukocyte α-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 45, 863-871.
8. COSTANZI, J.J., COOPER, M.R., SCARFFE, J.H., OZER, H., GRUBBS, S.S., FERRARESI, R.W., POLLARD, R.B., and SPIEGEL, R.J. (1985). The use of recombinant alpha-2 interferon in patients with resistant and relapsing multiple myeloma. J. Clin. Oncol. 3, 654-659.
9. FOON, K.A., SHERWIN, S.A., and ABRAMS, P.G. (1984). Treatment of advanced non-Hodgkins lymphoma with recombinant leukocyte A interferon. N. Engl. J. Med. 311, 1148-1152.
10. IKIC, D., NOLA, P., MARICIC, Z., SMUDJ, K., ORESIC, V., KNEZEVIC, M., RODE, B., JUSIC, D., and SOOS, E. (1981). Application of human leukocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma. Lancet (May 9), 1, 1022-1024.
11. CREAGAN, E.T., AHMANN, D.L., GREEN, S.J., LONG, H.J., RUBIN, J., SCHUTT, A.J., and DZIEWANOWSKI, Z.E. (1984). Phase II study of recombinant leukocyte A interferon (rIFN-αA) in disseminated malignant melanoma. Cancer 54, 2844-2849.
12. HAKANSSON, A., GUSTAFSSON, B., KRYSANDER, L., and HAKANSSON, L. (1998). Effect of IFN-α on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma. J. Interferon Cytokine Res. 18, 33-39.
13. HERSEY, P. (1986). The evolving role of alpha interferon in the treatment of malignancies. Aust. N.Z. J. Med. 16, 425-437.
14. DIAMANDIDOU, E., COHEN, P.R., and KURZROCK, R. (1996). Mycosis fungoides and Sezary syndrome. Blood 88, 2385-2490.
15. SPIEGEL, R.J. (1987). The alpha interferons: Clinical overview. Semin. Oncol. 14, 1-12.
16. OKITA, K., and KANEKO, T. (1990). The potential of interferons in malignant disease. Drugs 39, 1-6.
17. BOCCI, V. (1984). Evaluation of routes of administration of interferon in cancer: a review and a proposal. Cancer Drug Deliv. 1, 337-351.
18. VON WUSSOV, P., BLOCK, B., HARTMANN, F., and DEICHER, H. (1988). Intralesional interferon-alpha therapy in advanced malignant melanoma. Cancer 61, 1071-1074.
19. ND ed. pp. 2489-2494.
20. KRAINICK, V., KANTARJIAN, H., BROUSSARD, S., and TALPAZ, M. (1998). Local cutaneous necrotizing lesions associated with interferon injections. J. Interferon Cytokine Res. 18, 823-827.
21. CUMMINS, J.M. (1985). Method of Regulating Appetite and Efficiency of Food Utilization Employing Interferon. US Patent No. 4,497,795.
22. CUMMINS, J.M., TOMPKINS, M.B., OLSEN, R.G., TOMPKINS, W.A., and LEWIS, M.G. (1988). Oral use of human alpha interferon in cats. J. Biol. Response Mod. 7, 513-523.
23. STANTON, G.J., HUGHES, T.L., HEARD, H.K., GEORGIADES, J., and WHORTON, E. (1990). Modulation of a natural virus defense system by low concentrations of interferons at mucosal surfaces. J. Interferon Res. 10, S99.
24. HOLMAN, G. (1987). Unpublished observations, Amarillo, Texas.
25. LIEBERMAN, M.D., and DALY, J.M. (1991). Malnutrition and Cancer. In: Comprehensive Textbook of Oncology. A.R. Moosa et al. (eds.) Baltimore: Williams and Wilkins, vol. 2, p. 1684.
26. KINNULA, V., MATTSON, K., and CANTELL, K. (1989). Pharmacokinetics and toxicity of inhaled human interferon-α in patients with lung cancer. J. Interferon Res. 9, 419-423.
27. VAN ZANDWIJK, N., JASSEM, E., DUBBELMANN, R., BRAAT, M.C., and RUMKE, P. (1990). Aerosol application of interferon-alpha in the treatment of bronchioloalveolar carcinoma. Eur. J. Cancer 26, 738-740.
28. DHINGRA, K., DIMERY, I., MCLAUGHLIN, P., ROTHBERG, J.M., and GUTTERMAN, J.U. (1991). A phase 1 trial of buccal administration of low-dose recombinant alpha interferon (Roferon A). Proc. Annu. Meet. Am. Soc. Clin. Oncol. 10, 215.
29. DHINGRA, K., DUVIC, M., HYMES, S., MCLAUGHLIN, P., ROTHENBERG, J., and GUTTERMAN, J.U. (1993). A phase-I clinical study of low-dose oral interferon-α. J. Immunother. 14, 51-55.
30. PLATA-SALAMAN, C.R. (1992). Interferons and central regulation of feeding. Am. J. Physiol. 263, R1222-R1227.